| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.34 | 4e-23 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-18 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-16 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.26 | 1e-14 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.48 | 3e-14 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.24 | 9e-14 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.23 | 9e-13 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.37 | 2e-12 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-11 |